Research tenders in Finland.

Finland’s research & development market is governed by a distorted value curve. A few large construction and infrastructure programmes pull the average to EUR 795K, while the median is only EUR 140K. The gap is not a statistical footnote.

It changes the commercial model. A supplier that plans around rare mega contracts will misread the market, overbuild its offer, and wait too long. The median opportunity is the better guide to packaging, pricing, delivery capacity, and bid speed.

Read the market from the middle, not from the headline. Demand is broad rather than centralised. Municipalities, hospitals, universities, and state companies bring different briefs, approval cycles, and buying habits, yet each can generate recurring needs.

The task is not to chase the largest notice. It is to identify the buyers and categories where your capability matches a repeatable problem, then build familiarity before the next notice appears. Buyer concentration still matters because a small group controls most disclosed value, but that is a reason to map institutions carefully, not to treat the market as a single account.

Repetition beats reach. Value is concentrated at the top, but supplier access is wider than the spend profile suggests. 95% of winners took exactly one contract in the period.

That points to intense competition for individual awards, without a deeply entrenched repeat winner class. New entrants can therefore win when their evidence, scope, and response process fit a defined buyer need. The right target combines repeat demand, a manageable contract size, and capability you can prove quickly.

Compete where those conditions meet, and the market is open.